Immunological Changes after COVID-19 Vaccination in an HIV-Positive Patient

COVID-19 Outcomes Among Persons Living With or Without Diagnosed HIV Infection in New York State

(2021) James M. Tesoriero et al.   JAMA Network Open

Human Immunodeficiency Virus/AIDS in the Era of Coronavirus Disease 2019: A Juxtaposition of 2 Pandemics

(2021) Robert W Eisinger et al.   JOURNAL OF INFECTIOUS DISEASES

Safety and immunogenicity of a recombinant tandem-repeat dimeric RBD-based protein subunit vaccine (ZF2001) against COVID-19 in adults: two randomised, double-blind, placebo-controlled, phase 1 and 2 trials

(2021) Shilong Yang et al.   LANCET INFECTIOUS DISEASES

Effect of 2 Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults

(2021) Nawal Al Kaabi et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Acute Immune Thrombocytopenia (ITP) Following COVID-19 Vaccination in a Patient With Previously Stable ITP

(2021) Muzamil Jawed et al.   Open Forum Infectious Diseases

Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial

(2020) Maheshi N Ramasamy et al.   LANCET

Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine

(2020) Lindsey R. Baden et al.   NEW ENGLAND JOURNAL OF MEDICINE

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

(2020) Fernando P. Polack et al.   NEW ENGLAND JOURNAL OF MEDICINE

Sharing CD4+ T Cell Loss: When COVID-19 and HIV Collide on Immune System

(2020) Xiaorong Peng et al.   Frontiers in Immunology

Adverse events after vaccination among HIV-positive persons, 1990–2016

(2018) John R. Su et al.   PLoS One

Safety and Immunogenicity of an Adjuvanted Herpes Zoster Subunit Candidate Vaccine in HIV-Infected Adults: A Phase 1/2a Randomized, Placebo-Controlled Study

(2014) Elchonon M. Berkowitz et al.   JOURNAL OF INFECTIOUS DISEASES